Testosterone reduces cumulative burying in female Wistar rats with minimal participation of estradiol

Pharmacology Biochemistry and Behavior

Volumn 93, Issue 4, 2009, Pages 406-412

  Gutiérrez García, Ana G ^a   Contreras, Carlos M ^a,b   Vásquez Hernández, Diana I ^a   Molina Jiménez, Tania ^a   Jacome Jacome, Emma ^a  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Anxiety; Defensive burying test; Estradiol; Formestane; Tamoxifen; Testosterone

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ESTRADIOL; ESTRADIOL RECEPTOR; FORMESTANE; PICROTOXIN; PROGESTERONE; TAMOXIFEN; TESTOSTERONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; AROMATIZATION; ARTICLE; BLOOD SAMPLING; CHEMICAL INTERACTION; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE DETERMINATION; LATENT PERIOD; LOCOMOTION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RAT; TESTOSTERONE BLOOD LEVEL; TRANQUILIZING ACTIVITY; WISTAR RAT;

ANDROSTENEDIONE; ANIMALS; ANTI-ANXIETY AGENTS; AROMATASE INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GABA ANTAGONISTS; GABA-A RECEPTOR ANTAGONISTS; MOTOR ACTIVITY; PICROTOXIN; RATS; RATS, WISTAR; RECEPTORS, GABA-A; TAMOXIFEN; TESTOSTERONE;

RATTUS; RATTUS NORVEGICUS;

EID: 67849106370     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.06.002     Document Type: Article

References (73)

1. Adler G.K., Kinsley B.T., Hurwitz S., Mossey C.J., and Goldenberg D.L. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 106 (1999) 534-543
2. Aikey J.L., Nyby J.G., Anmuth D.M., and James P.J. Testosterone rapidly reduces anxiety in male house mice (Mus musculus). Horm Behav 42 (2002) 448-460
3. Bellido C., Martín de las Mulas J., Tena-Sempere M., Aguilar R., Alonso R., and Sánchez-Criado J.E. Tamoxifen induces gonadotropin-releasing hormone self-priming through an estrogen-dependent progesterone receptor expression in the gonadotrope of the rat. Neuroendocrinology 77 (2003) 425-435
4. Bing O., Heilig M., Kakoulidis P., Sundblad C., Wiklund L., and Eriksson E. High doses of testosterone increase anticonflict behavior in rat. Eur Neuropsychopharmacol 8 (1998) 321-323
5. A receptor. Brain Res 561 (1991) 157-161
6. A receptors in the rat. Horm Behav 27 (1993) 568-583
7. A receptors. J Neuroendocrinol 7 (1995) 171-177
8. Boissy A., and Bouissou M.F. Effects of androgen treatment on behavioral and physiological responses of heifers to fear-eliciting situations. Horm Behav 28 (1994) 66-83
9. Bouissou M.F., and Vandenheede M. Long-term effects of androgen treatment on fear reactions in ewes. Horm Behav 30 (1996) 93-99
10. Ceccarelli I., De Padova A.M., Fiorenzani P., Massafra C., and Aloisi A.M. Single opioid administration modifies gonadal steroids in both the CNS and plasma of male rats. Neuroscience 140 (2006) 929-937
11. Ceccarelli I., Della Seta D., Fiorenzani P., Farabollini F., and Aloisi A.M. Estrogenic chemicals at puberty change ERα in the hypothalamus of male and female rats. Neurotoxicol Teratol 29 (2007) 108-115
12. Cloitre M., Stovall-McClough K.C., Miranda R., and Chemtob C.M. Therapeutic alliance, negative mood regulation, and treatment outcome in child abuse-related posttraumatic stress disorder. J Consult Clin Psychol 72 (2004) 411-416
13. De Boer S.F., and Koolhaas J.M. Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol 463 (2003) 145-161
14. Domek D., Niekrasz I., Garnica A., and Seale T.W. The potent and rapid behavior-specific actions of androgens. Soc Neurosci Abstr 18 (1992) 814
15. Donath J., and Nishino Y. Effects of partial versus pure antiestrogens on ovulation and the pituitary-ovarian axis in the rat. J Steroid Biochem Mol Biol 66 (1998) 247-254
16. Dowsett M. Drug and hormone interactions of aromatase inhibitors. Endocr Relat Cancer 6 (1999) 181-185
17. Edinger K.L., and Frye C.A. Testosterone's analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of it's 5α-reduced metabolites in the hippocampus. Behav Neurosci 118 (2004) 1352-1364
18. Edinger K.L., and Frye C.A. Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5α-reduced metabolites in the hippocampus. Psychoneuroendocrinology 30 (2005) 418-430
19. Fernández-Guasti A., Hong E., and López-Rubalcava C. Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produces the anxiolytic action. Psychopharmacology (Berlin) 107 (1992) 61-68
20. Fernández-Guasti A., Martínez-Mota L., Estrada-Camarena E., Contreras C.M., and López-Rubalcava C. Chronic treatment with desipramine induces an estrous cycle-dependent anxiolytic-like action in the burying behavior, but not in the elevated plus-maze test. Pharmacol Biochem Behav 63 (1999) 13-20
21. Fernández-Guasti A., and Martínez-Mota L. Anxiolytic-like actions of testosterone in the burying behavior test: role of androgen and GABA-benzodiazepine receptors. Psychoneuroendocrinology 30 (2005) 762-770
22. Fernández-Guasti A., and Martínez-Mota L. Orchidectomy sensitizes male rats to the action of diazepam on burying behavior latency: role of testosterone. Pharmacol Biochem Behav 75 (2003) 473-479
23. Freeman M.E. The ovarian cycle of the rat. In: Knobil E., and Neill J. (Eds). The physiology of reproduction (1988), Raven Press, New York 1893-1928
24. Frye C.A. The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res Rev 37 (2001) 201-222
25. Frye C.A., Koonce C.J., Edinger K.L., Osborne D.M., and Walf A.A. Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice. Horm Behav 54 (2008) 726-734
26. Frye C.A., and Lacey E.H. Posttraining androgens' enhancement of cognitive performance is temporally distinct from androgens' increases in affective behavior. Cogn Affect Behav Neurosci 1 (2001) 172-182
27. Frye C.A., Petralia S.M., and Rhodes M.E. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3α,5α-THP. Pharmacol Biochem Behav 67 (2000) 587-596
28. Frye C.A., and Seliga A.M. Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats. Cogn Affect Behav Neurosci 1 (2001) 371-381
29. Frye C.A., and Walf A.A. Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 41 (2002) 306-315
30. Gee K.W., Bolger M.B., Brinton R.E., Coirini H., and McEwen B.S. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther 246 (1988) 803-812
31. Gonzalez M.I., Farabollini F., Albonetti E., and Wilson C.A. Interactions between 5-hydroxytryptamine (5-HT) and testosterone in the control of sexual and nonsexual behaviour in male and female rats. Pharmacol Biochem Behav 47 (1994) 591-601
32. A agonist TPI, but not of the neurosteroid 3α,5β-pregnanolone in the rat. Psychopharmacology 172 (2004) 283-290
33. Hermans E.J., Putman P., Baas J.M., Koppeschaar H.P., and van Honk J. A single administration of testosterone reduces fear-potentiated startle in humans. Biol Psychiatry 59 (2006) 872-874
34. Kessler R.C. Epidemiology of women and depression. J Affect Disord 74 (2003) 5-13
35. 1A agonists. Behav Pharmacol 5 (1994) 42-51
36. Maggi A., and Perez J. Progesterone and estrogens in rat brain: modulation of GABA (γ-aminobutyric acid) receptor activity. Eur J Pharmacol 103 (1984) 165-168
37. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
38. Martínez-Mota L., Estrada-Camarena E., López-Rubalcava C., Contreras C.M., and Fernández-Guasti A. Interaction of desipramine with steroid hormones on experimental anxiety. Psychoneuroendocrinology 25 (2000) 109-120
39. Miller W.R. Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer. Semin Oncol 30 4 Suppl 14 (2003) 3-11
40. Misiewicz B., Griebler C., Gomez M., Raybourne R., Zelazowska E., Gold P.W., et al. The estrogen antagonist tamoxifen inhibits carrageenan induced inflammation in LEW/N female rats. Life Sci 58 (1996) PL281-6
41. National Research Council. Guide for the Care and Use of Laboratory Animals. Publication 85-23 (1985), National Academy Press, Washington DC revised 1985
42. Osborne, D.M., Edinger, K., Frye, C.A. Chronic administration of androgens with actions at estrogen receptor beta have anti-anxiety and cognitive-enhancing effects in male rats. Age (Dordr) 2009;31:119-26.
43. Panzer C., and Guay A. Testosterone replacement therapy in naturally and surgically menopausal women. J Sex Med 6 (2009) 8-18
44. Patchev A.V., Götz F., and Rohde W. Differential role of estrogen receptor isoforms in sex-specific brain organization. FASEB J 18 (2004) 1568-1570
45. Picazo O., and Fernández-Guasti A. Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test. Brain Res 680 (1995) 135-141
46. Pinel J.P., and Treit D. Burying as a defensive response in rats. J Comp Physiol Psychol 92 (1978) 708-712
47. Rapkin A.J., Morgan M., Sogliano C., Biggio G., and Concas A. Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes. Fertil Steril 85 (2006) 1371-1378
48. Rhodes M.E., Balestreire E.M., Czambel R.K., and Rubin R.T. Estrous cycle influences on sexual diergism of HPA axis responses to cholinergic stimulation in rats. Brain Res Bull 59 (2002) 217-225
49. Roselli C.E., Abdelgadir S.E., Rønnekleiv O.K., and Klosterman S.A. Anatomic distribution and regulation of aromatase gene expression in the rat brain. Biol Reprod 58 (1998) 79-87
50. A receptors in the dorsal hippocampus by estradiol and progesterone. Brain Res 487 (1989) 178-183
51. Sherwin B.B. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 14 (1988) 177-187
52. Sherwin B.B., and Gelfand M.M. Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 151 (1985) 153-160
53. Simard J., Luthy I., Guay J., Belanger A., and Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol 44 (1986) 261-270
54. Simpson E.R. Aromatase: biologic relevance of tissue-specific expression. Semin Reprod Med 22 (2004) 11-23
55. Simpson E.R. Aromatization of androgens in women: current concepts and findings. Fertil Steril 77 Suppl 4 (2002) S6-10
56. Somboonporn W., and Davis S.R. Postmenopausal testosterone therapy and breast cancer risk. Maturitas 49 (2004) 267-275
57. Toufexis D.J., Myers K.M., and Davis M. The effect of gonadal hormones and gender on anxiety and emotional learning. Horm Behav 50 (2006) 539-549
58. Treit D. Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 9 (1985) 203-222
59. Turner D.M., Ransom R.W., Yang J.S., and Olsen R.W. Steroid anesthetics and naturally occurring analogs modulate the γ-aminobutyric acid receptor complex at a site distinct from barbiturates. J Pharmacol Exp Ther 248 (1989) 960-966
60. Valdes Jr. R., and Jortani S.A. Unexpected suppression of immunoassay results by cross-reactivity: now a demonstrated cause for concern. Clin Chem 48 (2002) 405-406
61. Van Honk, Peper J.S., and Schutter D.J. Testosterone reduces unconscious fear but not consciously experienced anxiety: implications for the disorders of fear and anxiety. Biol Psychiatry 58 (2005) 218-225
62. Wagner C.K., and Morrell J.I. Neuroanatomical distribution of aromatase mRNA in the rat brain: indications of regional regulation. J Steroid Biochem Mol Biol 61 (1997) 307-314
63. Walf A.A., and Frye C.A. Anxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity. Neuropsychopharmacology 30 (2005) 1288-1301
64. Walf A.A., and Frye C.A. ERβ-Selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology 30 (2005) 1598-1609
65. Walf A.A., Koonce C.J., and Frye C.A. Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor beta knockout, mice. Behav Neurosci 122 (2008) 974-981
66. Walf A.A., Koonce C., Manley K., and Frye C.A. Proestrous compared to diestrous wildtype, but not estrogen receptor beta knockout, mice have better performance in the spontaneous alternation and object recognition tasks and reduced anxiety-like behavior in the elevated plus and mirror maze. Behav Brain Res 196 (2009) 254-260
67. Walker W.H., and Cheng J. FSH and testosterone signaling in Sertoli cells. Reproduction 130 (2005) 15-28
68. Watanabe T., Inoue S., Ogawa S., Ishii Y., Hiroi H., Ikeda K., et al. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors α and β. Biochem Biophys Res Commun 236 (1997) 140-145
69. Wing L.Y., Garret W.M., and Brodie A.M.H. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors. Cancer Res 45 (1985) 2425-2428
70. Yuan H., Bowlby D.A., Brown T.J., Hochberg R.B., and Maclusky N.J. Distribution of occupied and unoccupied estrogen receptors in the rat brain: effects of physiological gonadal steroid exposure. Endocrinology 136 (1995) 96-105
71. Zaccheo T., Giudici D., and Di Salle E. Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats. J Steroid Biochem Mol Biol 44 (1993) 677-680
72. A receptor α2 subunit in upregulated by testosterone in rat cerebral cortex. Neurosci Lett 265 (1999) 25-28
73. Zhou J., Ng S., Adesanya-Famuiya O., Anderson K., and Bondy C.A. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 14 (2000) 1725-1730